Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovenox for Prevention of Vein Thrombosis Post-Splenectomy
NCT00769873Phase 2Terminated
- Sponsor
- University of Alberta
- Start
- Oct 2006
- Primary completion
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in portal vein thrombosis (PVT), splenic vein thrombosis (SVT), sponsored by University of Alberta. Started Oct 2006; status: terminated.
02
Drugs
enoxaparin
03
Conditions
portal vein thrombosis (PVT)splenic vein thrombosis (SVT)
Beyond the preview
Go deeper on NCT00769873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769873.